Supplement Ingredient Availability Snapshot: Q3 2026 Creatine Report
A dated, sourced status report on creatine supply for supplement brands. Statuses come from the branded ingredient reference; market context is cited inline. Updated quarterly.
Last reviewed: July 1, 2026
The Q3 2026 picture in short
Creatine supply is running in two different lanes right now. German-made branded creatine monohydrate (Creapure and Creavitalis, both Alzchem brands) is constrained: the owner reports demand has outstripped supply and says it must turn down or delay new business while prioritizing long-term customers, with new production capacity expected to begin commissioning in late 2027. Generic creatine monohydrate remains open on the commodity market, where an estimated 80 to 85 percent of global output comes from Chinese fine-chemical clusters. Spot prices spiked through late 2025 into early 2026; supplier-side data show prices easing by mid-2026, while demand for the branded German material still exceeds available supply.
The practical read for a supplement brand: if your formula names Creapure or Creavitalis on the label, allocation risk is the constraint to plan around. If it specifies generic creatine monohydrate, price volatility and import costs are.
Creatine availability board, Q3 2026
Each status is dated and sourced on the linked entity page. Default is Unknown: a status is published only with dated evidence, and statuses older than 90 days fail our build until re-assessed against current sources.
| Ingredient | Form | Owner | Access | Availability |
|---|---|---|---|---|
| Creapure® | creatine monohydrate | Alzchem Trostberg GmbH | Licensed program | Constrainedas of Jul 2026 |
| Creavitalis® | creatine monohydrate | Alzchem Group AG | Licensed program | Constrainedas of Jul 2026 |
| Con-Cret® | creatine hydrochloride (creatine HCl) | Vireo Systems, Inc. | Licensed program | Unknown |
| Kre-Alkalyn® | pH-buffered creatine monohydrate | All American Pharmaceutical & Natural Foods Corporation | Licensed program | Unknown |
| Creatine monohydrate (generic) | creatine monohydrate | Not applicable (generic) | Open market | Openas of Jul 2026 |
What is behind the Q3 2026 statuses
Demand outgrew supply
Alzchem told trade press in May 2026 that demand for its creatine brands has tripled in two years and now exceeds available inventory. The same coverage cites US creatine sales up 60.6 percent year over year, and new formats such as creatine gummies keep widening the buyer base.
- NutraIngredients: Alzchem confronts capacity pressures as demand for creatine booms (2026-05-28)
- Nutraceuticals World: creatine gummies boom (SPINS growth data) (2026-07-01)
Production is concentrated
A June 2026 supply-chain report estimates that over 80 percent of global creatine monohydrate output, roughly 80 to 85 percent, comes from integrated fine-chemical clusters in China's Shandong, Jiangsu, and Hebei provinces. Alzchem, producing in Germany, describes itself as the only creatine producer outside Asia. Concentration is why single-region events, from energy costs to export logistics, move the whole market at once.
- Guidechem: 2026 creatine monohydrate supply chain report (2026-06-04)
- Alzchem investor news: only creatine producer outside Asia (2025-12-16)
Prices spiked, then started easing
Creatine has cycled through squeezes before: in the 2021 to 2022 cycle, a supply-chain manager quoted in consumer press reported bulk prices moving from roughly 5 dollars per kilogram to more than 40 before normalizing. In the current cycle, one US brand publicly reported its container cost rising roughly 700 percent in about a year, from 85,500 dollars to a 630,000 dollar spot quote in January 2026; that is a single-brand account, not a market average, and the same account reports suppliers invoking force majeure on existing purchase agreements. Supplier-side market analyses report prices easing from that peak through mid-2026 as supply stabilizes. The easing applies to the generic commodity lane; Alzchem reported its branded material still demand-constrained as of May 2026.
- BarBend: inside the creatine shortage (2021-2022 cycle) (updated 2024-07-26)
- NutraBio (brand account): container-price progression and force majeure (2026-01-08)
- Caloong Chem (supplier-side analysis): 2026 downward correction after a high cycle (2026, May transaction data)
New capacity is coming, slowly
Alzchem announced an investment program of around 120 million euros, with staged commissioning of new creatine capacity expected from late 2027. Until that capacity lands, the owner reports prioritizing long-term customers, which is what the Constrained status in the table reflects.
Import costs sit on top of market prices
Most US creatine is imported, so duties on Chinese-origin ingredients add landed-cost pressure on top of whatever the market is doing. Rates change with trade policy; for current planning numbers, use the tariff estimator.
How to verify supply claims yourself
Any availability claim, including ours, should be checkable. When a supplier or manufacturer tells you an ingredient is available:
- Get the commitment in writing.A dated quote with a lead time and an order quantity. During a squeeze, a verbal "we can get it" is not a commitment.
- Verify branded material with the owner.For licensed ingredients, use the owner's own verification program (Creapure runs a seal-code lookup, for example) rather than taking a reseller's word for the license.
- Ask where it ships from. Production site and per-lot provenance, with a certificate of analysis that names the testing lab. Material of unknown origin gets cheaper and more common in every shortage.
- Pin down the price basis. FOB origin or landed US, which purity grade, and how long the quote holds. Spot quotes taken during a spike are not contract prices.
- Ask what happens under allocation. This cycle produced public brand accounts of force majeure being invoked on existing purchase orders. Ask how your order is treated if supply tightens again.
Dated status detail for each ingredient sits on its entity page, linked from the table above and from the availability board.
Method and cadence
Table statuses come from our branded-ingredient reference data: dated, source-classed, and defaulting to Unknown when evidence is missing. Statuses older than 90 days fail our build until re-assessed, so the table cannot silently go stale. Reporting manufacturers are never named. Market context above cites trade press, owner statements, one attributed brand account, and supplier-side analyses, each dated inline. This is the Q3 2026 edition; the Q4 2026 edition follows on the same quarterly data-collection cadence. Corrections are welcome via the link below.
What this snapshot does not tell you
- Whether a licensing program will accept your specific application. Owners decide that; we track reported status.
- Live inventory or today's price. Statuses are dated snapshots and prices move faster than any quarterly edition.
- Anything about ingredient efficacy. This is an identity and sourcing reference; we do not publish efficacy claims.
- Contract terms, minimum volumes, or pricing. Those come from owners and their distributors.
Sourcing creatine for a production run? The ingredient suppliers directory lists assessed suppliers, or describe your project and we will point you at matching vendors.
All trademarks are the property of their respective owners. Inventory Ready is independent. It is not affiliated with, licensed by, or endorsed by any ingredient owner referenced here. Word marks are referenced under nominative fair use; logos and quality seals are never reproduced.
Represent an ingredient owner, or see something out of date? Request a correction.